Quantcast

Latest Clinical research Stories

2014-09-30 23:23:50

For generic drugmakers, Oct. 1 is crunch time, the date after which all ANDA amendment and prior-approval supplement applications must meet new performance goals under the Generic Drug User Fee Amendments (GDUFA) of 2012. Joan Janulis, a Hatch-Waxman pro and all-around expert on FDA regulation in the generic drug industry, will help attendees read between the lines of the GDUFA performance metrics, associated guidance documents and MAPPs, and provide a roadmap to the post-GDUFA paradigm....

2014-09-30 23:23:48

Having FDA-regulated products held at ports costs time, money and the competitive edge. Here’s the one interactive workshop that arms attendees with a full program of today’s best compliance strategies for speeding products out of Customs and into US and global markets. Falls Church, VA (PRWEB) September 30, 2014 Building a World-Class Import/Export Program: How to Comply with the FDA and US Customs **Presented Encore Insight LLC and FDAnews** Oct. 27-28, 2014 – Bethesda, MD...

2014-09-30 23:19:33

Clinovo’s ClinCapture® system will provide ease of use and advanced functionality for Synergy MOSCOW, Russia (PRWEB) September 30, 2014 In a move that will deliver advanced functionality, as well as better data capture and management functions for sponsors, Synergy Research Group has chosen Clinovo’s ClinCapture electronic data capture (EDC) system. ClinCapture offers advanced out-of-the-box features that will give Synergy the ability to easily manage clinical trial data and...

2014-09-30 23:13:09

Transparency Market Research has published a new report titled "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report database. Albany, New York (PRWEB) September 30, 2014 The biological drugs market encompasses a class of medicine that is developed through genetic modification of monoclonal antibodies. Monoclonal antibodies naturally inhabit the human immune system and help the body in fighting from a variety of...

2014-09-30 23:11:13

MarketOptimizer.org adds “Pericarditis Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Pericarditis. Dallas, Texas (PRWEB) September 30, 2014 Clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2014″ provides data on the Pericarditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pericarditis. It includes...

2014-09-30 23:06:10

MarketOptimizer.org adds “Hyperemia Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Hyperemia. Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014″ provides data on the Hyperemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperemia. It includes an overview of...

2014-09-30 23:04:46

MarketOptimizer.org adds “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Idiopathic (Essential) Hypertension. Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014″ provides data on the Idiopathic (Essential) Hypertension clinical trial scenario. This report provides...

2014-09-30 23:03:49

MarketOptimizer.org adds “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Occlusive Arterial Disease (OAD). Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014″ provides data on the Occlusive Arterial Disease (OAD) clinical trial scenario. This report provides elemental...

2014-09-30 20:23:13

OTTAWA, Sept. 30, 2014 /CNW/ - Protecting the health and safety of Canadians is our government's highest priority. Our expectation is that Health Canada uses the appropriate powers and tools at its disposal to help ensure that the drugs Canadians need meet the highest safety and quality standards. To that end, Health Canada has taken decisive action today to stop the import into Canada of all drug products from three plants in India. They are: -- Apotex Pharmachem India Pvt Ltd --...

2014-09-30 20:23:04

? Risk-Based Monitoring Solution Recognized at SCDM Annual Conference ? NEWTOWN, Pa., Sept. 30, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related